FTC and DOJ to Host Listening Sessions on Lowering Americans’ Drug Prices Through Competition

Sessions to Discuss Generic and Biosimilar Availability, Prescription Drug Formularies and Benefits, and Regulatory Barriers

As part of implementing President Trump’s Executive Order No.View Press Release